InsidersTradesSigma
Track the Alligator Bioscience AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Alligator Bioscience AB has recorded 9 reports. Market capitalisation: €31.7m. The latest transaction was reported on 24 December 2025 (Purchase). Among the most active insiders: Peter Ostler. The full history is free.
9
Insider Decl.
n/a
Thresholds
€52,713
3 ops.
Buy Volume
n/a
1 ops.
Sell Volume
33Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 December 2025
Declarations9 total
824,138 shares@ €0.03660.021% mcap100.0% of flowTeckningsrätt/UniträttISIN SE0027098468FI:A003V045-1
736,729 shares0Teckningsrätt/UniträttISIN SE0027098450FI:A003U994-1
20,823 shares@ €0.2840.0042% mcap29.7% of flowAktieISIN SE0024173637FI:A003S445-1
23,456 shares@ €0.28570.0048% mcap29.7% of flowAktieISIN SE0024173637FI:A003S331-1
10,000 shares@ €0.28570.0020% mcap100.0% of flowAktieISIN SE0024173637FI:A003S326-1
41,649 shares@ €0.33560.0099% mcap70.3% of flowAktieISIN SE0024173637FI:A003P440-1
46,912 shares@ €0.33780.011% mcap70.3% of flowAktieISIN SE0024173637FI:A003O690-1
20,000 shares@ €0.33780.0048% mcap100.0% of flowAktieISIN SE0024173637FI:A003O552-1
1,200,833 shares0Teckningsrätt/UniträttISIN SE0015346390FI:A001P591-1
9 of 9 declarations
About Alligator Bioscience AB
Alligator Bioscience AB is a biopharmaceutical company focused on developing immuno-oncology therapies. It is listed on the Stockholm Stock Exchange (XSTO).